首页> 外文期刊>Anti-cancer drugs >Effects of mutations in the F361 to R364 region of topoisomerase I (Topo I), in the presence and absence of 9-aminocamptothecin, on the Topo I-DNA interaction.
【24h】

Effects of mutations in the F361 to R364 region of topoisomerase I (Topo I), in the presence and absence of 9-aminocamptothecin, on the Topo I-DNA interaction.

机译:在存在和不存在9-氨基喜树碱的情况下,拓扑异构酶I(Topo I)的F361至R364区域中的突变对Topo I-DNA相互作用的影响。

获取原文
获取原文并翻译 | 示例
       

摘要

Steady-state levels and rates of DNA binding and release of wild-type and mutant topoisomerase I (Topo I) proteins were quantified by surface plasmon resonance analysis. The proteins were constructed and expressed as GST fusion proteins. The Topo I mutations analyzed were F361S, R362L and R364G, all altering a highly conserved region of wild-type eukaryotic Topo I. The R362L and R364G mutations resulted in much lower steady-state levels of DNA binding than wild-type. This was due to a large increase in the k(d). The F361S mutation increased the steady-state levels of the protein-DNA interaction by increasing the k(a) 2-fold, while having little effect on the k(d). The F361S mutation has been shown to confer resistance to camptothecin and its analogs. The camptothecin analog 9-aminocamptothecin decreased greatly the overall k(d) of the wild-type Topo I, but had little effect on the F361S mutant. Both the wild-type and the F361S mutant exhibited decreased steady-state levels in the presence of the drug, and this was attributable to decreased association.
机译:通过表面等离子体共振分析定量测定稳态水平和DNA结合率以及野生型和突变型拓扑异构酶I(Topo I)蛋白的释放。蛋白质被构建并表达为GST融合蛋白。分析的Topo I突变为F361S,R362L和R364G,它们均改变了野生型真核Topo I的高度保守区域。R362L和R364G突变导致稳态DNA结合水平低于野生型。这是因为k(d)大大增加了。 F361S突变通过增加k(a)2倍来增加蛋白质-DNA相互作用的稳态水平,而对k(d)的影响很小。 F361S突变已显示赋予喜树碱及其类似物抗性。喜树碱类似物9-氨基喜树碱大大降低了野生型Topo I的总体k(d),但对F361S突变体影响很小。在药物存在下,野生型和F361S突变体均表现出降低的稳态水平,这归因于缔合的降低。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号